Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 894 participants.
Also called NCT01685840
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 894 participants
- Registry
-
NCT01685840
-
- Other papers using this trial's data
- Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial
- Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score
- Differences in NT-proBNP Response and Prognosis in Men and Women With Heart Failure With Reduced Ejection Fraction
- Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure
- Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial
- NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF
- Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction
- Obesity and Serial NT-proBNP Levels in Guided Medical Therapy for Heart Failure With Reduced Ejection Fraction: Insights From the GUIDE-IT Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Terminated
Technical summary
Registry record NCT01685840. Randomized; no masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2016-09-20 (actual). Results posted on 2017-12-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Guiding Evidence Based Therapy Using Biomarker Intensified Treatment
- Acronym
- GUIDE-IT
- Condition
- Heart Failure
- Intervention (Other)
- Usual Care
- Intervention (Device)
- Biomarker-guided care NT-proBNP (natriuretic peptide)
- Lead sponsor
- Duke University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct01685840- Content hash
f6f399c09cb1a62d09793680084cf2026de8d20ecf6a4c0b494e1e409e1083c4